These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9725390)

  • 21. Does off-pump revascularization reduce coronary endothelial dysfunction?
    Lazar HL; Bao Y; Rivers S
    J Card Surg; 2004; 19(5):440-3. PubMed ID: 15383057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient.
    Lazar HL
    Ann Thorac Surg; 2005 Mar; 79(3):1081-9. PubMed ID: 15734453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
    Schwarz ER; Montino H; Fleischhauer J; Klues HG; vom Dahl J; Hanrath P
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):687-95. PubMed ID: 9493708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
    Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
    Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy.
    Kyriakidis M; Triposkiadis F; Dernellis J; Androulakis AE; Mellas P; Kelepeshis GA; Gialafos JE
    Circulation; 1998 Apr; 97(14):1342-7. PubMed ID: 9577944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
    Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble complement receptor type I limits damage during revascularization of ischemic myocardium.
    Lazar HL; Hamasaki T; Bao Y; Rivers S; Bernard SA; Shemin RJ
    Ann Thorac Surg; 1998 Apr; 65(4):973-7. PubMed ID: 9564912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective?
    Adams JA; Wu D; Bassuk J; Arias J; Lozano H; Kurlansky P; Lamas GA
    Resuscitation; 2007 Sep; 74(3):516-25. PubMed ID: 17466432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.
    Ebrahim Z; Yellon DM; Baxter GF
    Exp Gerontol; 2007 Aug; 42(8):807-14. PubMed ID: 17532161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
    Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C;
    Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide.
    Fujii M; Avkiran M; Chambers DJ
    Ann Thorac Surg; 2004 Apr; 77(4):1398-407. PubMed ID: 15063274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy.
    Rouleau JR; Simard D; Blouin A; Kingma JG
    Basic Res Cardiol; 2002 Sep; 97(5):384-91. PubMed ID: 12200638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.